Opioid-induced respiratory depression (ORD) presents a significant risk, particularly in patients with obesity, sleep apnea, chronic obstructive pulmonary disease, and those undergoing surgeries with a high risk of postoperative respiratory failure. Meta-analyses and studies, such as those by Cashman and Dolin, highlight the varying incidence of ORD based on factors like administration route, opioid type, and study methodology, underscoring the risk of brain damage and death post-surgery. Analysis of the Anesthesia Closed Claims Project Database reveals that most ORD cases occur within 24 hours post-surgery, often after patient transfer from the post-anesthesia care unit (PACU), with death being the most common outcome.
Gastrointestinal dysfunction, notably postoperative ileus, can lead to complications such as anastomotic leaks in bowel surgery. Liberal opioid use in major surgeries may cause abdominal distension, pushing the diaphragm upward, leading to atelectasis and increased breathing work, potentially resulting in postoperative respiratory failure and re-intubation. Additionally, opioid-induced gastroparesis contributes to aspiration risks during anesthesia induction and impedes nasogastric feed absorption in the critical care unit, suggesting a shift towards alternative sedatives like dexmedetomidine.
Other notable problems can also manifest as a result of using opioids. Opioid-induced postoperative nausea and vomiting (PONV) is particularly problematic following surgeries that increase bleeding or cerebrospinal fluid leak risks due to the Valsalva maneuver. Pruritus, often more distressing than pain, is inadequately managed with antihistamines due to their sedation side effects. Urinary retention, necessitating catheterization, can lead to infections, while opioids also heighten postoperative delirium risks, which can be mitigated by alternative pain management strategies. Furthermore, opioids may suppress cell-mediated immunity and potentially increase tumor recurrence rates post-cancer surgery, warranting cautious use.
The broad range of opioid side effects underscores the need for careful perioperative use. The evidence stresses the importance of exploring alternative analgesics and methods to mitigate opioid-related adverse effects and improve patient outcomes.
| Effect | Why it matters |
|---|---|
| Respiratory depression | Highest risk with obesity, sleep apnea, COPD, and surgery carrying high risk of postoperative respiratory failure; most cases occur within 24 hours of surgery, often after transfer out of the PACU, with death the most common outcome |
| Postoperative ileus | Can lead to anastomotic leaks in bowel surgery |
| Abdominal distension | Pushes the diaphragm upward → atelectasis and increased work of breathing → possible respiratory failure and re-intubation |
| Gastroparesis | Aspiration risk at induction; impairs nasogastric feed absorption in critical care |
| PONV | Especially problematic after surgery where the Valsalva maneuver raises bleeding or CSF leak risk |
| Pruritus | Often more distressing than pain; poorly managed with antihistamines because of their sedation |
| Urinary retention | Requires catheterization, which can lead to infection |
| Delirium | Risk heightened postoperatively; can be reduced with alternative pain strategies |
| Immune effects | May suppress cell-mediated immunity and potentially increase tumor recurrence after cancer surgery |
